The changing epidemiology of candida species in Asia Pacific and evidence for optimizing antifungal dosing in challenging clinical scenarios

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This review highlights antifungal resistance issues and the need for better dosing strategies in critically ill patients in Asia Pacific.

The global burden of invasive fungal infections is rising, driven by antifungal resistance.
Candida species show changing epidemiology in the Asia Pacific, complicating treatment.
Suboptimal dosing of antifungals in critically ill patients can lead to poor therapeutic outcomes.
Therapeutic drug monitoring is crucial for optimizing antifungal therapy in challenging clinical scenarios.

Chen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark